The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug.
The global Loxoprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Loxoprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Loxoprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Loxoprofen in Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Loxoprofen include Boehringer Ingelheim, Eisai, Lead Chemical Co.,Ltd, Shanghai Xudong Haipu Pharmaceutical, Xingan Pharmaceutical, Hunan Jiudian Pharmaceutical, Jilin Yinglian Biopharmaceutical, Ningbo Lihua Pharmaceutical and Shandong Yuxin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Loxoprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Loxoprofen.
Report Scope
The Loxoprofen market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Loxoprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Loxoprofen companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Eisai
Lead Chemical Co.,Ltd
Shanghai Xudong Haipu Pharmaceutical
Xingan Pharmaceutical
Hunan Jiudian Pharmaceutical
Jilin Yinglian Biopharmaceutical
Ningbo Lihua Pharmaceutical
Shandong Yuxin Pharmaceutical
Daiichi Sankyo Pharmaceutical
Shanghai Disha Pharmaceutical Group
Chongqing Kerui Pharmaceutical Group
Shandong Weigao Pharmaceutical
Shandong Qidu Pharmaceutical
Jinhong Pharmaceutical
Segment by Type
Tablets
Capsule
Patch
Segment by Application
Nonsteroidal Anti-Inflammatory Drugs
Topical Administration for Joint And Muscle Pain
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loxoprofen companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug.
The global Loxoprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Loxoprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Loxoprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Loxoprofen in Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Loxoprofen include Boehringer Ingelheim, Eisai, Lead Chemical Co.,Ltd, Shanghai Xudong Haipu Pharmaceutical, Xingan Pharmaceutical, Hunan Jiudian Pharmaceutical, Jilin Yinglian Biopharmaceutical, Ningbo Lihua Pharmaceutical and Shandong Yuxin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Loxoprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Loxoprofen.
Report Scope
The Loxoprofen market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Loxoprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Loxoprofen companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Eisai
Lead Chemical Co.,Ltd
Shanghai Xudong Haipu Pharmaceutical
Xingan Pharmaceutical
Hunan Jiudian Pharmaceutical
Jilin Yinglian Biopharmaceutical
Ningbo Lihua Pharmaceutical
Shandong Yuxin Pharmaceutical
Daiichi Sankyo Pharmaceutical
Shanghai Disha Pharmaceutical Group
Chongqing Kerui Pharmaceutical Group
Shandong Weigao Pharmaceutical
Shandong Qidu Pharmaceutical
Jinhong Pharmaceutical
Segment by Type
Tablets
Capsule
Patch
Segment by Application
Nonsteroidal Anti-Inflammatory Drugs
Topical Administration for Joint And Muscle Pain
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loxoprofen companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Loxoprofen Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Patch
1.3 Market by Application
1.3.1 Global Loxoprofen Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Nonsteroidal Anti-Inflammatory Drugs
1.3.3 Topical Administration for Joint And Muscle Pain
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Loxoprofen Market Perspective (2019-2030)
2.2 Loxoprofen Growth Trends by Region
2.2.1 Global Loxoprofen Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Loxoprofen Historic Market Size by Region (2019-2024)
2.2.3 Loxoprofen Forecasted Market Size by Region (2025-2030)
2.3 Loxoprofen Market Dynamics
2.3.1 Loxoprofen Industry Trends
2.3.2 Loxoprofen Market Drivers
2.3.3 Loxoprofen Market Challenges
2.3.4 Loxoprofen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Loxoprofen Players by Revenue
3.1.1 Global Top Loxoprofen Players by Revenue (2019-2024)
3.1.2 Global Loxoprofen Revenue Market Share by Players (2019-2024)
3.2 Global Loxoprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Loxoprofen Revenue
3.4 Global Loxoprofen Market Concentration Ratio
3.4.1 Global Loxoprofen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Loxoprofen Revenue in 2023
3.5 Loxoprofen Key Players Head office and Area Served
3.6 Key Players Loxoprofen Product Solution and Service
3.7 Date of Enter into Loxoprofen Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Loxoprofen Breakdown Data by Type
4.1 Global Loxoprofen Historic Market Size by Type (2019-2024)
4.2 Global Loxoprofen Forecasted Market Size by Type (2025-2030)
5 Loxoprofen Breakdown Data by Application
5.1 Global Loxoprofen Historic Market Size by Application (2019-2024)
5.2 Global Loxoprofen Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Loxoprofen Market Size (2019-2030)
6.2 North America Loxoprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Loxoprofen Market Size by Country (2019-2024)
6.4 North America Loxoprofen Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Loxoprofen Market Size (2019-2030)
7.2 Europe Loxoprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Loxoprofen Market Size by Country (2019-2024)
7.4 Europe Loxoprofen Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Loxoprofen Market Size (2019-2030)
8.2 Asia-Pacific Loxoprofen Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Loxoprofen Market Size by Region (2019-2024)
8.4 Asia-Pacific Loxoprofen Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Loxoprofen Market Size (2019-2030)
9.2 Latin America Loxoprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Loxoprofen Market Size by Country (2019-2024)
9.4 Latin America Loxoprofen Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Loxoprofen Market Size (2019-2030)
10.2 Middle East & Africa Loxoprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Loxoprofen Market Size by Country (2019-2024)
10.4 Middle East & Africa Loxoprofen Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Loxoprofen Introduction
11.1.4 Boehringer Ingelheim Revenue in Loxoprofen Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Loxoprofen Introduction
11.2.4 Eisai Revenue in Loxoprofen Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Lead Chemical Co.,Ltd
11.3.1 Lead Chemical Co.,Ltd Company Detail
11.3.2 Lead Chemical Co.,Ltd Business Overview
11.3.3 Lead Chemical Co.,Ltd Loxoprofen Introduction
11.3.4 Lead Chemical Co.,Ltd Revenue in Loxoprofen Business (2019-2024)
11.3.5 Lead Chemical Co.,Ltd Recent Development
11.4 Shanghai Xudong Haipu Pharmaceutical
11.4.1 Shanghai Xudong Haipu Pharmaceutical Company Detail
11.4.2 Shanghai Xudong Haipu Pharmaceutical Business Overview
11.4.3 Shanghai Xudong Haipu Pharmaceutical Loxoprofen Introduction
11.4.4 Shanghai Xudong Haipu Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.4.5 Shanghai Xudong Haipu Pharmaceutical Recent Development
11.5 Xingan Pharmaceutical
11.5.1 Xingan Pharmaceutical Company Detail
11.5.2 Xingan Pharmaceutical Business Overview
11.5.3 Xingan Pharmaceutical Loxoprofen Introduction
11.5.4 Xingan Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.5.5 Xingan Pharmaceutical Recent Development
11.6 Hunan Jiudian Pharmaceutical
11.6.1 Hunan Jiudian Pharmaceutical Company Detail
11.6.2 Hunan Jiudian Pharmaceutical Business Overview
11.6.3 Hunan Jiudian Pharmaceutical Loxoprofen Introduction
11.6.4 Hunan Jiudian Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.6.5 Hunan Jiudian Pharmaceutical Recent Development
11.7 Jilin Yinglian Biopharmaceutical
11.7.1 Jilin Yinglian Biopharmaceutical Company Detail
11.7.2 Jilin Yinglian Biopharmaceutical Business Overview
11.7.3 Jilin Yinglian Biopharmaceutical Loxoprofen Introduction
11.7.4 Jilin Yinglian Biopharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.7.5 Jilin Yinglian Biopharmaceutical Recent Development
11.8 Ningbo Lihua Pharmaceutical
11.8.1 Ningbo Lihua Pharmaceutical Company Detail
11.8.2 Ningbo Lihua Pharmaceutical Business Overview
11.8.3 Ningbo Lihua Pharmaceutical Loxoprofen Introduction
11.8.4 Ningbo Lihua Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.8.5 Ningbo Lihua Pharmaceutical Recent Development
11.9 Shandong Yuxin Pharmaceutical
11.9.1 Shandong Yuxin Pharmaceutical Company Detail
11.9.2 Shandong Yuxin Pharmaceutical Business Overview
11.9.3 Shandong Yuxin Pharmaceutical Loxoprofen Introduction
11.9.4 Shandong Yuxin Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.9.5 Shandong Yuxin Pharmaceutical Recent Development
11.10 Daiichi Sankyo Pharmaceutical
11.10.1 Daiichi Sankyo Pharmaceutical Company Detail
11.10.2 Daiichi Sankyo Pharmaceutical Business Overview
11.10.3 Daiichi Sankyo Pharmaceutical Loxoprofen Introduction
11.10.4 Daiichi Sankyo Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.10.5 Daiichi Sankyo Pharmaceutical Recent Development
11.11 Shanghai Disha Pharmaceutical Group
11.11.1 Shanghai Disha Pharmaceutical Group Company Detail
11.11.2 Shanghai Disha Pharmaceutical Group Business Overview
11.11.3 Shanghai Disha Pharmaceutical Group Loxoprofen Introduction
11.11.4 Shanghai Disha Pharmaceutical Group Revenue in Loxoprofen Business (2019-2024)
11.11.5 Shanghai Disha Pharmaceutical Group Recent Development
11.12 Chongqing Kerui Pharmaceutical Group
11.12.1 Chongqing Kerui Pharmaceutical Group Company Detail
11.12.2 Chongqing Kerui Pharmaceutical Group Business Overview
11.12.3 Chongqing Kerui Pharmaceutical Group Loxoprofen Introduction
11.12.4 Chongqing Kerui Pharmaceutical Group Revenue in Loxoprofen Business (2019-2024)
11.12.5 Chongqing Kerui Pharmaceutical Group Recent Development
11.13 Shandong Weigao Pharmaceutical
11.13.1 Shandong Weigao Pharmaceutical Company Detail
11.13.2 Shandong Weigao Pharmaceutical Business Overview
11.13.3 Shandong Weigao Pharmaceutical Loxoprofen Introduction
11.13.4 Shandong Weigao Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.13.5 Shandong Weigao Pharmaceutical Recent Development
11.14 Shandong Qidu Pharmaceutical
11.14.1 Shandong Qidu Pharmaceutical Company Detail
11.14.2 Shandong Qidu Pharmaceutical Business Overview
11.14.3 Shandong Qidu Pharmaceutical Loxoprofen Introduction
11.14.4 Shandong Qidu Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.14.5 Shandong Qidu Pharmaceutical Recent Development
11.15 Jinhong Pharmaceutical
11.15.1 Jinhong Pharmaceutical Company Detail
11.15.2 Jinhong Pharmaceutical Business Overview
11.15.3 Jinhong Pharmaceutical Loxoprofen Introduction
11.15.4 Jinhong Pharmaceutical Revenue in Loxoprofen Business (2019-2024)
11.15.5 Jinhong Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Loxoprofen Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Patch
Table 5. Global Loxoprofen Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Loxoprofen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Loxoprofen Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Loxoprofen Market Share by Region (2019-2024)
Table 9. Global Loxoprofen Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Loxoprofen Market Share by Region (2025-2030)
Table 11. Loxoprofen Market Trends
Table 12. Loxoprofen Market Drivers
Table 13. Loxoprofen Market Challenges
Table 14. Loxoprofen Market Restraints
Table 15. Global Loxoprofen Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Loxoprofen Market Share by Players (2019-2024)
Table 17. Global Top Loxoprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Loxoprofen as of 2023)
Table 18. Ranking of Global Top Loxoprofen Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Loxoprofen Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Loxoprofen Product Solution and Service
Table 22. Date of Enter into Loxoprofen Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Loxoprofen Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Loxoprofen Revenue Market Share by Type (2019-2024)
Table 26. Global Loxoprofen Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Loxoprofen Revenue Market Share by Type (2025-2030)
Table 28. Global Loxoprofen Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Loxoprofen Revenue Market Share by Application (2019-2024)
Table 30. Global Loxoprofen Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Loxoprofen Revenue Market Share by Application (2025-2030)
Table 32. North America Loxoprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Loxoprofen Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Loxoprofen Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Loxoprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Loxoprofen Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Loxoprofen Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Loxoprofen Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Loxoprofen Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Loxoprofen Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Loxoprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Loxoprofen Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Loxoprofen Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Loxoprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Loxoprofen Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Loxoprofen Market Size by Country (2025-2030) & (US$ Million)
Table 47. Boehringer Ingelheim Company Detail
Table 48. Boehringer Ingelheim Business Overview
Table 49. Boehringer Ingelheim Loxoprofen Product
Table 50. Boehringer Ingelheim Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 51. Boehringer Ingelheim Recent Development
Table 52. Eisai Company Detail
Table 53. Eisai Business Overview
Table 54. Eisai Loxoprofen Product
Table 55. Eisai Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 56. Eisai Recent Development
Table 57. Lead Chemical Co.,Ltd Company Detail
Table 58. Lead Chemical Co.,Ltd Business Overview
Table 59. Lead Chemical Co.,Ltd Loxoprofen Product
Table 60. Lead Chemical Co.,Ltd Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 61. Lead Chemical Co.,Ltd Recent Development
Table 62. Shanghai Xudong Haipu Pharmaceutical Company Detail
Table 63. Shanghai Xudong Haipu Pharmaceutical Business Overview
Table 64. Shanghai Xudong Haipu Pharmaceutical Loxoprofen Product
Table 65. Shanghai Xudong Haipu Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 66. Shanghai Xudong Haipu Pharmaceutical Recent Development
Table 67. Xingan Pharmaceutical Company Detail
Table 68. Xingan Pharmaceutical Business Overview
Table 69. Xingan Pharmaceutical Loxoprofen Product
Table 70. Xingan Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 71. Xingan Pharmaceutical Recent Development
Table 72. Hunan Jiudian Pharmaceutical Company Detail
Table 73. Hunan Jiudian Pharmaceutical Business Overview
Table 74. Hunan Jiudian Pharmaceutical Loxoprofen Product
Table 75. Hunan Jiudian Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 76. Hunan Jiudian Pharmaceutical Recent Development
Table 77. Jilin Yinglian Biopharmaceutical Company Detail
Table 78. Jilin Yinglian Biopharmaceutical Business Overview
Table 79. Jilin Yinglian Biopharmaceutical Loxoprofen Product
Table 80. Jilin Yinglian Biopharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 81. Jilin Yinglian Biopharmaceutical Recent Development
Table 82. Ningbo Lihua Pharmaceutical Company Detail
Table 83. Ningbo Lihua Pharmaceutical Business Overview
Table 84. Ningbo Lihua Pharmaceutical Loxoprofen Product
Table 85. Ningbo Lihua Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 86. Ningbo Lihua Pharmaceutical Recent Development
Table 87. Shandong Yuxin Pharmaceutical Company Detail
Table 88. Shandong Yuxin Pharmaceutical Business Overview
Table 89. Shandong Yuxin Pharmaceutical Loxoprofen Product
Table 90. Shandong Yuxin Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 91. Shandong Yuxin Pharmaceutical Recent Development
Table 92. Daiichi Sankyo Pharmaceutical Company Detail
Table 93. Daiichi Sankyo Pharmaceutical Business Overview
Table 94. Daiichi Sankyo Pharmaceutical Loxoprofen Product
Table 95. Daiichi Sankyo Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 96. Daiichi Sankyo Pharmaceutical Recent Development
Table 97. Shanghai Disha Pharmaceutical Group Company Detail
Table 98. Shanghai Disha Pharmaceutical Group Business Overview
Table 99. Shanghai Disha Pharmaceutical Group Loxoprofen Product
Table 100. Shanghai Disha Pharmaceutical Group Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 101. Shanghai Disha Pharmaceutical Group Recent Development
Table 102. Chongqing Kerui Pharmaceutical Group Company Detail
Table 103. Chongqing Kerui Pharmaceutical Group Business Overview
Table 104. Chongqing Kerui Pharmaceutical Group Loxoprofen Product
Table 105. Chongqing Kerui Pharmaceutical Group Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 106. Chongqing Kerui Pharmaceutical Group Recent Development
Table 107. Shandong Weigao Pharmaceutical Company Detail
Table 108. Shandong Weigao Pharmaceutical Business Overview
Table 109. Shandong Weigao Pharmaceutical Loxoprofen Product
Table 110. Shandong Weigao Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 111. Shandong Weigao Pharmaceutical Recent Development
Table 112. Shandong Qidu Pharmaceutical Company Detail
Table 113. Shandong Qidu Pharmaceutical Business Overview
Table 114. Shandong Qidu Pharmaceutical Loxoprofen Product
Table 115. Shandong Qidu Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 116. Shandong Qidu Pharmaceutical Recent Development
Table 117. Jinhong Pharmaceutical Company Detail
Table 118. Jinhong Pharmaceutical Business Overview
Table 119. Jinhong Pharmaceutical Loxoprofen Product
Table 120. Jinhong Pharmaceutical Revenue in Loxoprofen Business (2019-2024) & (US$ Million)
Table 121. Jinhong Pharmaceutical Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Loxoprofen Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Loxoprofen Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Patch Features
Figure 6. Global Loxoprofen Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Loxoprofen Market Share by Application: 2023 VS 2030
Figure 8. Nonsteroidal Anti-Inflammatory Drugs Case Studies
Figure 9. Topical Administration for Joint And Muscle Pain Case Studies
Figure 10. Loxoprofen Report Years Considered
Figure 11. Global Loxoprofen Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Loxoprofen Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Loxoprofen Market Share by Region: 2023 VS 2030
Figure 14. Global Loxoprofen Market Share by Players in 2023
Figure 15. Global Top Loxoprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Loxoprofen as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Loxoprofen Revenue in 2023
Figure 17. North America Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Loxoprofen Market Share by Country (2019-2030)
Figure 19. United States Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Loxoprofen Market Share by Country (2019-2030)
Figure 23. Germany Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Loxoprofen Market Share by Region (2019-2030)
Figure 31. China Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Loxoprofen Market Share by Country (2019-2030)
Figure 39. Mexico Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Loxoprofen Market Share by Country (2019-2030)
Figure 43. Turkey Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Loxoprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Boehringer Ingelheim Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 46. Eisai Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 47. Lead Chemical Co.,Ltd Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 48. Shanghai Xudong Haipu Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 49. Xingan Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 50. Hunan Jiudian Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 51. Jilin Yinglian Biopharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 52. Ningbo Lihua Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 53. Shandong Yuxin Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 54. Daiichi Sankyo Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 55. Shanghai Disha Pharmaceutical Group Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 56. Chongqing Kerui Pharmaceutical Group Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 57. Shandong Weigao Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 58. Shandong Qidu Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 59. Jinhong Pharmaceutical Revenue Growth Rate in Loxoprofen Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
